Douglas G. Gray
Corporate Secretary chez BIOHAVEN LTD.
Profil
Douglas G.
Gray is currently a Partner & Chairman-Life Science Practice Group at Locke Lord LLP and also serves as Secretary at Biohaven Ltd.
He previously worked as Secretary & Director at Biohaven Pharmaceutical Holding Co. Ltd.
and as a Partner at Edwards Wildman Palmer LLP.
Gray received a graduate degree from the University of Notre Dame and an undergraduate degree from Yale University.
Postes actifs de Douglas G. Gray
| Sociétés | Poste | Début |
|---|---|---|
| BIOHAVEN LTD. | Corporate Secretary | - |
Locke Lord LLP
 Locke Lord LLP Miscellaneous Commercial ServicesCommercial Services Locke Lord LLP provides legal services. The private company is based in Houston, TX. | Corporate Officer/Principal | 01/01/2015 |
Anciens postes connus de Douglas G. Gray
| Sociétés | Poste | Fin |
|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Director/Board Member | 03/10/2022 |
Edwards Wildman Palmer LLP
 Edwards Wildman Palmer LLP Miscellaneous Commercial ServicesCommercial Services Edwards Wildman Palmer LLP is a private banking firm located in Boston, Massachusetts. | Corporate Officer/Principal | - |
Formation de Douglas G. Gray
| University of Notre Dame | Graduate Degree |
| Yale University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BIOHAVEN LTD. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Edwards Wildman Palmer LLP
Edwards Wildman Palmer LLP Miscellaneous Commercial ServicesCommercial Services Edwards Wildman Palmer LLP is a private banking firm located in Boston, Massachusetts. | Commercial Services |
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
Locke Lord LLP
Locke Lord LLP Miscellaneous Commercial ServicesCommercial Services Locke Lord LLP provides legal services. The private company is based in Houston, TX. | Commercial Services |
